公開日期 | 標題 | 作者 | 來源出版物 | scopus | WOS | 全文 |
2022 | PD-L1 strong expressions affect the clinical outcomes of osimertinib in treatment naïve advanced EGFR-mutant non-small cell lung cancer patients | Hsu, Kuo-Hsuan; Tseng, Jeng-Sen; Yang, Tsung-Ying; Chen, Kun-Chieh; KANG-YI SU ; SUNG-LIANG YU ; Chen, Jeremy J W; Huang, Yen-Hsiang; Chang, Gee-Chen | Scientific reports | 11 | 9 | |
2023 | Polygenic Risk Score, Environmental Tobacco Smoke, and Risk of Lung Adenocarcinoma in Never-Smoking Women in Taiwan | Blechter, Batel; Chien, Li-Hsin; Chen, Tzu-Yu; Chang, I-Shou; Choudhury, Parichoy Pal; Hsiao, Chin-Fu; Shu, Xiao-Ou; Wong, Jason Y Y; KUAN-YU CHEN ; Chang, Gee-Chen; Tsai, Ying-Huang; Su, Wu-Chou; Huang, Ming-Shyan; Chen, Yuh-Min; Chen, Chih-Yi; Hung, Hsiao-Han; Hu, Jia-Wei; Shi, Jianxin; Zheng, Wei; Rositch, Anne F; Chen, Chien-Jen; Chatterjee, Nilanjan; PAN-CHYR YANG ; Rothman, Nathaniel; Hsiung, Chao Agnes; Lan, Qing | JAMA network open | 0 | 0 | |
2020 | Predicting Lung Cancer Occurrence in Never-Smoking Females in Asia: TNSF-SQ, a Prediction Model | Chien, Li-Hsin; Chen, Chung-Hsing; Chen, Tzu-Yu; Chang, Gee-Chen; Tsai, Ying-Huang; Hsiao, Chin-Fu; KUAN-YU CHEN ; Su, Wu-Chou; Wang, Wen-Chang; Huang, Ming-Shyan; Chen, Yuh-Min; Chen, Chih-Yi; SHENG-KAI LIANG ; CHUNG-YU CHEN ; Wang, Chih-Liang; Lee, Mei-Hsuan; Chung, Ren-Hua; Tsai, Fang-Yu; Hu, Jia-Wei; Katki, Hormuzd A; Chatterjee, Nilanjan; Chanock, Stephen J; Rothman, Nathaniel; Lan, Qing; PAN-CHYR YANG ; Chen, Chien-Jen; Chang, I-Shou; Hsiung, Chao A | Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology | 26 | 23 | |
2024 | Primary tumor consolidative therapy improves the outcomes of patients with advanced EGFR-mutant lung adenocarcinoma treated with first-line osimertinib | Wu, Jia-Jun; Tseng, Jeng-Sen; Zheng, Zhe-Rong; Chu, Cheng-Hsiang; Chen, Kun-Chieh; MONG-WEI LIN ; Huang, Yen-Hsiang; Hsu, Kuo-Hsuan; Yang, Tsung-Ying; SUNG-LIANG YU ; JIN-SHING CHEN ; CHAO-CHI HO ; Chang, Gee-Chen | Therapeutic advances in medical oncology | 0 | | |
2021 | Primary Tumor Radiotherapy During EGFR-TKI Disease Control Improves Survival of Treatment Naïve Advanced EGFR-Mutant Lung Adenocarcinoma Patients | Hsu, Kuo-Hsuan; Huang, Jing-Wen; Tseng, Jeng-Sen; Chen, Kuan-Wen; Weng, Yih-Chyang; SUNG-LIANG YU ; Yang, Tsung-Ying; Huang, Yen-Hsiang; Chen, Jeremy J W; Chen, Kun-Chieh; Chang, Gee-Chen | OncoTargets and therapy | 6 | 6 | |
2021 | Primary Tumor Resection Is Associated with a Better Outcome among Advanced EGFR-Mutant Lung Adenocarcinoma Patients Receiving EGFR-TKI Treatment | Tseng, Jeng-Sen; Hsu, Kuo-Hsuan; Zheng, Zhe-Rong; Yang, Tsung-Ying; Chen, Kun-Chieh; Huang, Yen-Hsiang; KANG-YI SU ; SUNG-LIANG YU ; Chang, Gee-Chen | Oncology | 9 | 9 | |
2021 | Programmed Death Ligand 2 Gene Polymorphisms Are Associated With Lung Adenocarcinoma Risk in Female Never-Smokers | SHENG-KAI LIANG ; Chien, Li-Hsin; Chang, Gee-Chen; Tsai, Ying-Huang; Su, Wu-Chou; Chen, Yuh-Min; Huang, Ming-Shyan; Lin, Hsien-Chih; Fang, Wen-Tsen; Hung, Hsiao-Han; Jiang, Shih-Sheng; Chen, Chih-Yi; KUAN-YU CHEN ; Chang, I-Shou; Hsiung, Chao A; Chen, Chien-Jen; PAN-CHYR YANG | Frontiers in oncology | 4 | 4 | |
2020 | Proteogenomics of Non-smoking Lung Cancer in East Asia Delineates Molecular Signatures of Pathogenesis and Progression | Chen, Yi-Ju; Roumeliotis, Theodoros I; Chang, Ya-Hsuan; Chen, Ching-Tai; Han, Chia-Li; MIAO-HSIA LIN ; HUEI-WEN CHEN ; Chang, Gee-Chen; YIH-LEONG CHANG ; CHEN-TU WU ; MONG-WEI LIN ; MIN-SHU HSIEH ; Wang, Yu-Tai; Chen, Yet-Ran; Jonassen, Inge; Ghavidel, Fatemeh Zamanzad; Lin, Ze-Shiang; Lin, Kuen-Tyng; Chen, Ching-Wen; Sheu, Pei-Yuan; Hung, Chen-Ting; Huang, Ke-Chieh; Yang, Hao-Chin; Lin, Pei-Yi; Yen, Ta-Chi; Lin, Yi-Wei; Wang, Jen-Hung; Raghav, Lovely; Lin, Chien-Yu; Chen, Yan-Si; Wu, Pei-Shan; Lai, Chi-Ting; Weng, Shao-Hsing; KANG-YI SU ; Chang, Wei-Hung; Tsai, Pang-Yan; Robles, Ana I; Rodriguez, Henry; Hsiao, Yi-Jing; Chang, Wen-Hsin; Sung, Ting-Yi; JIN-SHING CHEN ; SUNG-LIANG YU ; Choudhary, Jyoti S; Chen, Hsuan-Yu; PAN-CHYR YANG ; Chen, Yu-Ju | Cell | 154 | 134 | |
2021 | Publisher Correction: The impact of different first-line EGFR-TKIs on the clinical outcome of sequential osimertinib treatment in advanced NSCLC with secondary T790M | Huang, Yen-Hsiang; Tseng, Jeng-Sen; Hsu, Kuo-Hsuan; Chen, Kun-Chieh; KANG-YI SU ; SUNG-LIANG YU ; Chen, Jeremy J W; Yang, Tsung-Ying; Chang, Gee-Chen | Scientific reports | 0 | 0 | |
2024 | Real-world evidence of lorlatinib therapy in Taiwanese patients with advanced anaplastic lymphoma kinase-positive non-small cell lung cancer | JIN-YUAN SHIH ; Luo, Yung-Hung; Chang, Gee-Chen; Chang, John Wen-Cheng; Wang, Chin-Chou; Yang, Tsung-Ying; Fang, Wei-Tse; Shau, Wen-Yi | Journal of the Formosan Medical Association = Taiwan yi zhi | | | |
2022 | Recalibrating Risk Prediction Models by Synthesizing Data Sources: Adapting the Lung Cancer PLCO Model for Taiwan | Chien, Li-Hsin; Chen, Tzu-Yu; Chen, Chung-Hsing; KUAN-YU CHEN ; Hsiao, Chin-Fu; Chang, Gee-Chen; Tsai, Ying-Huang; Su, Wu-Chou; Huang, Ming-Shyan; Chen, Yuh-Min; CHIH-YI CHEN ; SHENG-KAI LIANG ; CHUNG-YU CHEN ; Wang, Chih-Liang; Hung, Hsiao-Han; Jiang, Hsin-Fang; Hu, Jia-Wei; Rothman, Nathaniel; Lan, Qing; Liu, Tsang-Wu; Chen, Chien-Jen; PAN-CHYR YANG ; Chang, I-Shou; Hsiung, Chao A | Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology | 1 | 0 | |
2022 | Reduced symmetric dimethylation stabilizes vimentin and promotes metastasis in MTAP-deficient lung cancer | Chang, Wen-Hsin; Chen, Yi-Ju; Hsiao, Yi-Jing; Chiang, Ching-Cheng; Wang, Chia-Yu; Chang, Ya-Ling; Hong, Qi-Sheng; Lin, Chien-Yu; Lin, Shr-Uen; Chang, Gee-Chen; Chen, Hsuan-Yu; Chen, Yu-Ju; Chen, Ching-Hsien; PAN-CHYR YANG ; SUNG-LIANG YU | EMBO reports | 4 | 5 | |
2021 | The relative importance of predictive factors for single first-generation EGFR-TKI use for more than 5 years in patients with advanced non-small cell lung cancer: Taiwan multicenter TIPS-5 study | Huang, Yen-Hsiang; Hung, Jen-Yu; Ko, How-Wen; Su, Po-Lan; Lai, Chun-Liang; Chang, Huang-Chih; Hsia, Te-Chun; Lin, Sheng-Hao; Wu, Kuan-Li; Yang, Cheng-Ta; Su, Wu-Chou; Chu, Yi-Chun; Wang, Chin-Chou; WEI-YU LIAO ; YEN-TING LIN ; Lin, Ching-Hsiung; Lin, Meng-Chih; Hsu, Kuo-Hsuan; Tseng, Jeng-Sen; Yang, Tsung-Ying; Chen, Kun-Chieh; Lee, Mei-Hsuan; SUNG-LIANG YU ; CHAO-CHI HO ; Chang, Gee-Chen | Therapeutic advances in medical oncology | 3 | 2 | |
2013 | Risk factors for primary lung cancer among never smokers by gender in a matched case-control study | Lo, Yen-Li; Hsiao, Chin-Fu; Chang, Gee-Chen; Tsai, Ying-Huang; Huang, Ming-Shyan; Su, Wu-Chou; Chen, Yuh-Min; Hsin, Che-Wei; Chang, Chin-Hao; Yang, Pan-Chyr; Chen, Chien-Jen; Hsiung, Chao A. | Cancer Causes Control | | | |
2022 | Tissue Proteogenomic Landscape Reveals the Role of Uncharacterized SEL1L3 in Progression and Immunotherapy Response in Lung Adenocarcinoma | Chi-ya Shen; Chang, Wen-Hsin; Chen, Yi-Ju; Weng, Chia-Wei; Regmi, Prabha; Kier, Mickiela K K; KANG-YI SU ; Chang, Gee-Chen; JIN-SHING CHEN ; Chen, Yu-Ju; SUNG-LIANG YU | Journal of proteome research | 4 | 0 | |
2010 | Tumor suppressor HLJ1 switches the double-faced role of nucleophosmin through AP-2α complex formation | Chang, Tzu-Pei; Yu, Sung-Liang; Lin, Sheng-Yi; Hsia, Yi-Jing; Chang, Gee-Chen; Yang, Pan-Chyr; Chen, Jeremy J.W.; 張梓珮; 俞松良; 林聖怡; 蕭乂菁; 張基晟; 楊泮池; 陳健尉 | Cancer Research | | | |
2022 | Various impacts of driver mutations on the PD-L1 expression of NSCLC | Chu, Cheng-Hsiang; Huang, Yen-Hsiang; Lee, Po-Hsin; Hsu, Kuo-Hsuan; Chen, Kun-Chieh; KANG-YI SU ; SUNG-LIANG YU ; Tseng, Jeng-Sen; Yang, Tsung-Ying; Chang, Gee-Chen | PloS one | 3 | 1 | |
2023 | Whole exome sequencing and MicroRNA profiling of lung adenocarcinoma identified risk prediction features for tumors at stage I and its substages | Ho, Hao; SUNG-LIANG YU ; Chen, Hsuan-Yu; Yuan, Shin-Sheng; KANG-YI SU ; Hsu, Yi-Chiung; Hsu, Chung-Ping; Chuang, Cheng-Yen; Chang, Ya-Hsuan; Li, Yu-Cheng; Cheng, Chiou-Ling; Chang, Gee-Chen; PAN-CHYR YANG ; Li, Ker-Chau | Lung cancer (Amsterdam, Netherlands) | 0 | 0 | |